Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Dudley

Showing results (31-40 of 260) with videos related to

Pageof 26
Sort By:
The Journal of Antimicrobial Chemotherapy|May 1, 1991
Single daily dosing of amikacin in an in-vitro modelM N Dudley, S H Zinner
Diagnostic Microbiology and Infectious Disease|May 1, 1997
Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical responseR N Jones, M N Dudley
American Journal of Hospital Pharmacy|February 1, 1990
Potential effect of oral antimicrobial therapy on nurse staffing requirementsL L Lincoln, M N Dudley
Postgraduate Medical Journal|October 3, 2002
How informed is consent? Understanding of pictorial and verbal probability information by medical inpatientsR Fuller, N Dudley, J Blacktop
Current Opinion in Microbiology|October 26, 2000
Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime timeM N Dudley, P G Ambrose
Virginia Medical Monthly|October 29, 2010
The importance of cerebrospinal fluid examination in syphilisL W McILHANY, J N DUDLEY
Clinical Pharmacy|March 1, 1982
Cefotaxime: microbiology, pharmacology, and clinical useM N Dudley, S L Barriere
Pharmacotherapy|January 23, 1999
Human immunodeficiency virus protease inhibitorsK Z Rana, M N Dudley
The Journal of Antimicrobial Chemotherapy|November 1, 1986
Bactericidal activity of ciprofloxacin alone and in combination with azlocillin in an in-vitro capillary modelS H Zinner, M N Dudley
Age and Ageing|December 18, 2001
Risk communication and older people-understanding of probability and risk information by medical inpatients aged 75 years and olderR Fuller, N Dudley, J Blacktop
Pageof 26

Showing results (31-40 of 260) with videos related to

Sort By:
Pageof 26
The Journal of Antimicrobial Chemotherapy|May 1, 1991
Single daily dosing of amikacin in an in-vitro modelM N Dudley, S H Zinner
Diagnostic Microbiology and Infectious Disease|May 1, 1997
Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical responseR N Jones, M N Dudley
American Journal of Hospital Pharmacy|February 1, 1990
Potential effect of oral antimicrobial therapy on nurse staffing requirementsL L Lincoln, M N Dudley
Postgraduate Medical Journal|October 3, 2002
How informed is consent? Understanding of pictorial and verbal probability information by medical inpatientsR Fuller, N Dudley, J Blacktop
Current Opinion in Microbiology|October 26, 2000
Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime timeM N Dudley, P G Ambrose
Virginia Medical Monthly|October 29, 2010
The importance of cerebrospinal fluid examination in syphilisL W McILHANY, J N DUDLEY
Clinical Pharmacy|March 1, 1982
Cefotaxime: microbiology, pharmacology, and clinical useM N Dudley, S L Barriere
Pharmacotherapy|January 23, 1999
Human immunodeficiency virus protease inhibitorsK Z Rana, M N Dudley
The Journal of Antimicrobial Chemotherapy|November 1, 1986
Bactericidal activity of ciprofloxacin alone and in combination with azlocillin in an in-vitro capillary modelS H Zinner, M N Dudley
Age and Ageing|December 18, 2001
Risk communication and older people-understanding of probability and risk information by medical inpatients aged 75 years and olderR Fuller, N Dudley, J Blacktop
Pageof 26